News Sentiment

DNTH sentiment intelligence

Dianthus Therapeutics Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 97.60 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+3.5% over one week, +18.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Form 4 Dianthus Therapeutics Inc For: 13 July By Investing.com

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction 3.5% Price confirming higher
Trend fit Trend active 18.9% over four weeks
Fair value 194.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 33
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
Stock Titan 11
TradingView 10
Investing.com 3
Sahm 3
Finviz 2
www.marketscreener.com 2
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 16
Analyst action 2
Deals and strategy 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54